Recruiting TR-002 for the Treatment of Advanced Unresectable Metastatic Solid Tumors Unresectable or Metastatic, Refractory Pancreatic Adenocarcinoma NCT07189195 Conditions Advanced Malignant Solid Neoplasm, Digestive System Diseases, Digestive System Neoplasms, +17 more Locations University of California Davis Comprehensive Cancer Center — Sacramento, California, United States View Trial Details
Not Yet Recruiting JDB153 Combined With Serplulimab for Pancreatic Cancer After Standard Treatment Failure NCT07175389 Conditions Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +7 more Locations West China Hospital, Sichuan University — Chengdu, Sichuan, China View Trial Details
Completed SD-101, Nivolumab, and Radiation Therapy in Treating Patients With Chemotherapy-Refractory Metastatic Pancreatic Cancer NCT04050085 Conditions Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +8 more Locations University of California Davis Comprehensive Cancer Center — Sacramento, California, United States View Trial Details
